EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.5100
+0.0050 (0.99%)
Jun 19, 2026, 4:10 PM AEST
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 24 million as of June 18, 2026. Its market cap has decreased by -66.08% in one year.
Market Cap
24.00M
Enterprise Value
9.45M
Revenue
61.40M
Ranking
n/a
PE Ratio
8.31
Stock Price
0.51
Market Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has decreased from 48.72M to 24.00M, a decrease of -50.73%. That is a compound annual growth rate of -12.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 24.00M | -63.81% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
| Mar 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurizon Therapeutics | 46.27M |
| Nexsen | 45.04M |
| Patrys | 30.00M |
| Noxopharm | 22.43M |
| Algorae Pharmaceuticals | 21.24M |
| NeuroScientific Biopharmaceuticals | 20.62M |
| Neurotech International | 19.77M |
| Opthea | 19.15M |